Skip to main content
. Author manuscript; available in PMC: 2022 Apr 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2021 Apr 15;86(5):e139–e145. doi: 10.1097/QAI.0000000000002617

Table 1:

Characteristics of HIV seronegative and seropositive women at the index visit.

HIV-seronegative
(n=46)
HIV seropositive
(n=76)
P-value
Age (yr, Mean [SD]) 48.2 (5.03) 48.9 (4.89) 0.53
Height (m, Mean [SD]) 1.6 (0.07) 1.6 (0.07) 0.75
Weight (kg, Mean [SD]) 75.3 (13.9) 77.9 (15.3) 0.38
BMI (kg/m2, Mean [SD]) 28.4 (5.53) 29.4 (5.83) 0.46
Race (n, %)
    White 4 (8%) 11 (14%) 0.63
    Black 35 (77%) 58 (75%)
    Others 6 (13%) 8 (10%)
Menopause Status (n, %)
    Early perimenopause 18 (40) 30 (38%) 0.91
    Late perimenopause/Post-menopausal 27 (60%) 47 (61%)
Enrollment Site (n, %)
    Bronx/Manhattan 18 (40%) 28 (36%) 0.92
    San Francisco 14 (31%) 26 (33%)
    Chicago 13 (28%) 23 (29%)
Smoking Status (n, %)
    Former/Never 16 (35%) 32 (41%) 0.51
    Current 29 (64%) 45 (58%)
Hepatitis C Virus Infection (n, %)
    Negative 39 (86%) 61 (79%) 0.30
    Ab+RNA-/RNA unknow+RNA+ 6 (13%) 16 (20%)
Bone Turnover Markers (ng/ml)
    P1NP (Mean [SD]) 53.64 (17.6) 55.05 (26.2) 0.71
    CTX (Mean [SD]) 0.32 (0.2) 0.33 (0.18) 0.32
HIV Viral load
Detected (n, %) 27 (35%)
Undetected (n, %) 49 (64%)
CD4 count at index (Mean [SD]) 594.2 (269.2)
Nadir CD4 count at index (Mean [SD]) 302.4 (192.1)
ART use at Index (n, %) 74 (97%)
PI use at Index (n, %) 37 (49%)
INSTI use at Index (n, %) 68 (89%)
NNRTI use at Index (n, %) 37 (49%)